Lipid Conjugates Enhance Endosomal Release of Antisense Oligonucleotides Into Cells

被引:50
作者
Wang, Shiyu [1 ]
Allen, Nickolas [1 ]
Prakash, Thazha P. [2 ]
Liang, Xue-hai [1 ]
Crooke, Stanley T. [1 ]
机构
[1] Ionis Pharmaceut Inc, Dept Core Antisense Res, 2855 Gazelle Court, Carlsbad, CA 92010 USA
[2] Ionis Pharmaceut Inc, Dept Med Chem, Carlsbad, CA 92010 USA
关键词
antisense oligonucleotides; lipid conjugates; free fatty acids; intracellular trafficking; endosomal release; CELLULAR UPTAKE; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; INTRACELLULAR TRAFFICKING; TARGETED DELIVERY; PROTEINS; RECEPTORS;
D O I
10.1089/nat.2019.0794
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antisense oligonucleotides modified with phosphorothioate linkages (PS-ASOs) can enter cells via endocytic pathways and must escape from membraned organelles to reach target RNAs. We recently found that membrane destabilization induced by different lipid species contributes to PS-ASO release from late endosomes (LEs). In this study, we characterized intracellular uptake, trafficking, and activities of PS-ASOs conjugated with different lipid species. We found that palmitic acid-, tocopherol-, and cholesterol-conjugated PS-ASOs have increased protein binding and enhanced intracellular uptake compared to unconjugated PS-ASOs. Similar to the parental PS-ASO, the lipid-conjugated PS-ASOs traffic from early to LEs without incorporation into lipid droplets. Unlike parental PS-ASOs, the lipid-conjugated PS-ASOs tend to remain associated with plasma or endosomal membranes, and this appears to influence their release from endosomes. The lipid-conjugated PS-ASOs were released more rapidly than parental PS-ASO. These results suggest that lipid conjugation enhances the interactions of PS-ASOs with proteins or membranes, in turn facilitating intracellular trafficking and endosomal release.
引用
收藏
页码:245 / 255
页数:11
相关论文
共 34 条
  • [1] Alahari SK, 1996, MOL PHARMACOL, V50, P808
  • [2] BINDING, UPTAKE, AND INTRACELLULAR TRAFFICKING OF PHOSPHOROTHIOATE-MODIFIED OLIGODEOXYNUCLEOTIDES
    BELTINGER, C
    SARAGOVI, HU
    SMITH, RM
    LESAUTEUR, L
    SHAH, N
    DEDIONISIO, L
    CHRISTENSEN, L
    RAIBLE, A
    JARETT, L
    GEWIRTZ, AM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) : 1814 - 1823
  • [3] Quantitative fluorescence imaging determines the absolute number of locked nucleic acid oligonucleotides needed for suppression of target gene expression
    Buntz, Annette
    Killian, Tobias
    Schmid, Daniela
    Seul, Heike
    Brinkmann, Ulrich
    Ravn, Jacob
    Lindholm, Marie
    Knoetgen, Hendrik
    Haucke, Volker
    Mundigl, Olaf
    [J]. NUCLEIC ACIDS RESEARCH, 2019, 47 (02) : 953 - 969
  • [4] Oligonucleotides Conjugated to Natural Lipids: Synthesis of Phosphatidyl-Anchored Antisense Oligonucleotides
    Chillemi, Rosa
    Greco, Valentina
    Nicoletti, Vincenzo G.
    Sciuto, Sebastiano
    [J]. BIOCONJUGATE CHEMISTRY, 2013, 24 (04) : 648 - 657
  • [5] RNA-Targeted Therapeutics
    Crooke, Stanley T.
    Witztum, Joseph L.
    Bennett, C. Frank
    Baker, Brenda F.
    [J]. CELL METABOLISM, 2018, 27 (04) : 714 - 739
  • [6] Cellular uptake and trafficking of antisense oligonucleotides
    Crooke, Stanley T.
    Wang, Shiyu
    Vickers, Timothy A.
    Shen, Wen
    Liang, Xue-hai
    [J]. NATURE BIOTECHNOLOGY, 2017, 35 (03) : 230 - 237
  • [7] Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay
    Gaus, Hans J.
    Gupta, Ruchi
    Chappell, Alfred E.
    Ostergaard, Michael E.
    Swayze, Eric E.
    Seth, Punit P.
    [J]. NUCLEIC ACIDS RESEARCH, 2019, 47 (03) : 1110 - 1122
  • [8] Pharmacokinetics of a tumor necrosis factor-α phosphorothioate 2′-O-(2-methoxyethyl) modified antisense oligonucleotide:: Comparison across species
    Geary, RS
    Yu, RZ
    Watanabe, T
    Henry, SP
    Hardee, GE
    Chappell, A
    Matson, J
    Sasmor, H
    Cummins, L
    Levin, AA
    [J]. DRUG METABOLISM AND DISPOSITION, 2003, 31 (11) : 1419 - 1428
  • [9] Micelles of lipid-oligonucleotide conjugates:: Implications for membrane anchoring and base pairing
    Gosse, C
    Boutorine, A
    Aujard, I
    Chami, M
    Kononov, A
    Cogné-Laage, E
    Allemand, JF
    Li, J
    Jullien, L
    [J]. JOURNAL OF PHYSICAL CHEMISTRY B, 2004, 108 (20) : 6485 - 6497
  • [10] Fatty Acid-Modified Gapmer Antisense Oligonucleotide and Serum Albumin Constructs for Pharmacokinetic Modulation
    Hvam, Michael Lykke
    Cai, Yunpeng
    Dagnaes-Hansen, Frederik
    Nielsen, Jesper Sejrup
    Wengel, Jesper
    Kjems, Jorgen
    Howard, Kenneth A.
    [J]. MOLECULAR THERAPY, 2017, 25 (07) : 1710 - 1717